Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07107165

Adapting After Discharge From Allogeneic Stem Cell Transplant: Dyadic Intervention to Improve Patient and Family Caregiver Management

Led by University of Pittsburgh · Updated on 2026-04-01

208

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

U

University of Pittsburgh

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating two brief psychosocial interventions to support patients who have undergone stem cell transplant and their family caregivers in managing medical regimens after hospital discharge. This randomized clinical trial aims to find out if either intervention improves psychological well-being and health-related outcomes for both patients and caregivers. The study is led by the University of Pittsburgh and focuses on the post-discharge period following allogeneic hematopoietic cell transplantation. Participants will be randomly assigned to one of two groups: the Dyadic Problem Solving Training (DPST) group or the Supportive Care group. Both interventions consist of four sessions delivered via live video conferencing. DPST teaches problem-solving skills to help manage the medical regimen, while Supportive Care provides emotional and practical support. Each group includes 52 patient-caregiver pairs, and the interventions aim to improve adherence and perceived task efficacy. Participants and their caregivers will complete questionnaires before the intervention and at 1, 5, 12, and 24 weeks afterward. Researchers will assess health habits, perceived task efficacy, medication levels, healthcare use, mood, anxiety, relationship adjustment, and caregiver reactions. The study includes close monitoring through repeated assessments over 24 weeks, allowing detailed evaluation of how the interventions affect daily management and well-being post-transplant.

CONDITIONS

Brief Title

Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient undergoing a stem cell transplant at the University of Pittsburgh Hillman Cancer Center
  • 18 years or older
  • Having a family caregiver 18 years or older also willing to participate
  • Willing to accept randomization
Not Eligible

You will not qualify if you...

  • Prior history of stem cell transplant
  • Non-English speaking

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person or remote)

Outpatient Treatment

Duration - 4 sessions

Participants receive one of two psychosocial interventions via live video conferencing to help manage the medical regimen after stem cell transplant.

4 video conferencing sessions

Follow-up

Duration - 24 weeks post-intervention

Participants complete questionnaires to assess health habits, task efficacy, and other psychosocial outcomes after the intervention.

Questionnaires at 1, 5, 12, and 24 weeks post-intervention

Trial Site Locations

Total: 1 location

1

University of Pittsburgh Medical Center Hillman Cancer Center

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

Loading map...

Research Team

D

Donna Posluszny, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transpl...

Cancer Distress

Actively Recruiting

1 location

Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem ...

Stem Cell Transplant

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies.

Donna M Posluszny, Dana H Bovbjerg, Karen L Syrjala...

https://pubmed.ncbi.nlm.nih.gov/30022348

Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.

Donna M Posluszny, Dana H Bovbjerg, Karen L Syrjala...

https://pubmed.ncbi.nlm.nih.gov/34875403